Potential Benefits of Combining Proton or Carbon Ion Therapy with DNA Damage Repair Inhibitors
Cells · 2024
DOI: 10.3390/cells13121058 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, 2024. Verfasst von Gro Elise Rødland und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Biology, Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital, 0379 Oslo, Norway. Hauptthemen laut MEDLINE: DNA Repair, DNA Damage, Proton Therapy, Heavy Ion Radiotherapy. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 142 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Norway Romania, The Norwegian Cancer Society.
Abstract (Originalsprache)
The use of charged particle radiotherapy is currently increasing, but combination therapy with DNA repair inhibitors remains to be exploited in the clinic. The high-linear energy transfer (LET) radiation delivered by charged particles causes clustered DNA damage, which is particularly effective in destroying cancer cells. Whether the DNA damage response to this type of damage is different from that elicited in response to low-LET radiation, and if and how it can be targeted to increase treatment efficacy, is not fully understood. Although several preclinical studies have reported radiosensitizing effects when proton or carbon ion irradiation is combined with inhibitors of, e.g., PARP, ATR, ATM, or DNA-PKcs, further exploration is required to determine the most effective treatments. Here, we examine what is known about repair pathway choice in response to high- versus low-LET irradiation, and we discuss the effects of inhibitors of these pathways when combined with protons and carbon ions. Additionally, we explore the potential effects of DNA repair inhibitors on antitumor immune signaling upon proton and carbon ion irradiation. Due to the reduced effect on healthy tissue and better immune preservation, particle therapy may be particularly well suited for combination with DNA repair inhibitors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Biology, Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital, 0379 Oslo, Norway.
- Department of Life and Environmental Physics, Horia Hulubei National Institute of Physics and Nuclear Engineering, 077125 Magurele, Romania.
- UMR6252 CIMAP, Team Applications in Radiobiology with Accelerated Ions, CEA-CNRS-ENSICAEN-Université de Caen Normandie, 14000 Caen, France.
ORCID-Profile: Mihaela Temelie, François Chevalier, Diana I Savu
Förderung
- Norway Romania
- The Norwegian Cancer Society
Zitieren
APA
Rødland, G. E., Temelie, M., Eek Mariampillai, A., Hauge, S., Gilbert, A., Chevalier, F., Savu, D. I., & Syljuåsen, R. G. (2024). Potential Benefits of Combining Proton or Carbon Ion Therapy with DNA Damage Repair Inhibitors. Cells. https://doi.org/10.3390/cells13121058
Vancouver
Rødland GE, Temelie M, Eek Mariampillai A, Hauge S, Gilbert A, Chevalier F, et al. Potential Benefits of Combining Proton or Carbon Ion Therapy with DNA Damage Repair Inhibitors. Cells. 2024. doi:10.3390/cells13121058
BibTeX
@article{Rdland2024,
author = {Rødland, Gro Elise and Temelie, Mihaela and Eek Mariampillai, Adrian and Hauge, Sissel and Gilbert, Antoine and Chevalier, François and Savu, Diana I and Syljuåsen, Randi G},
title = {Potential Benefits of Combining Proton or Carbon Ion Therapy with DNA Damage Repair Inhibitors},
journal = {Cells},
year = {2024},
doi = {10.3390/cells13121058}
}
EUVIMED